Sanara MedTech, Inc SMTI 深 滬
已收盤 11-14 16:00:00 美东时间
21.54
+1.930
+9.84%
華盛通- 最 高22.65
- 今 開19.61
- 成交量 10.84万股
- 最 低 19.5189
- 昨 收 19.61
- 總市值 1.92亿
- 52周最高 38.75
- 市盈率 靜 --
- 換手率 1.22%
- 52周最低 19.10
- 委 比 82.65%
- 總股本 890.24万
- 歷史最高 53.85
- 量 比 0.87
- 振 幅 15.97%
- 歷史最低 17.41
- 每 手 1
- 風險率 3.35%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sanara MedTech Q3 EPS $(3.40) Misses $(0.21) Estimate, Sales $26.334M Miss $26.625M Estimate
Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(3.40) per share which missed the analyst consensus estimate of $(0.21) by 1481.4 percent. This is a 900 percent decrease over losses of $(0.34) per share from
11-12 20:03
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
Sanara MedTech Discontinuing Operations Of Tissue Health Plus To Enhance Operating Efficiency, Reallocate Resources To Core Surgical Business
Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and
11-12 05:09
Sanara MedTech appoints new CEO
Sanara MedTech (NASDAQ:SMTI) has named Seth Yon as president and chief executive officer, effective September 15, 2025. Yon will also join the company’s board. Yon succeeds Ron Nixon, who will remain ...
09-03 04:50
Sanara MedTech Inc. Announces Chief Executive Officer Transition
Sanara MedTech Inc. announced that Seth Yon has been appointed as President, CEO, and Director, effective September 15, 2025. He will succeed Ron Nixon, who remains as Executive Chairman. Yon joined the company in 2018 and has held several senior roles, contributing to significant revenue growth. Nixon praised Yon's leadership and ability to drive the company's future success. Yon expressed excitement to lead Sanara through its next phase of grow...
09-02 20:30
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
Sanara MedTech Inc. (Nasdaq: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare costs, announced that its management will present at the Cantor Global Healthcare Conference in New York on September 2-5, 2025. The fireside chat will occur on September 3 at 2:45 p.m. ET. Conference materials and a live audio webcast will be available on the Company’s investor relations website. Sanara develops and com...
08-27 20:05
HC Wainwright & Co. Maintains Buy on Sanara MedTech, Raises Price Target to $54
HC Wainwright & Co. analyst Yi Chen maintains Sanara MedTech (NASDAQ:SMTI) with a Buy and raises the price target from $53 to $54.
08-18 19:24
Sanara MedTech reports Q2 results
Sanara MedTech press release (NASDAQ:SMTI): Q2 GAAP EPS of -$0.23. Revenue of $25.8M (+27.7% Y/Y). Adjusted EBITDA of $2.7M, compared to $0.6M in the second quarter of 2024. More on Sanara MedTech San...
08-13 19:33
Sanara MedTech Q2 EPS $(0.23) Beats $(0.44) Estimate, Sales $25.831M Beat $25.150M Estimate
Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.44) by 47.73 percent. This is a 43.9 percent increase over losses of $(0.41) per share from the
08-13 19:02
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
